Evidence map›Paper›PMID 37647980›Full record

ArticleInternational journal of pharmaceutics2023

Manufacturing pharmaceutical mini-tablets for pediatric patients using drop-on-demand printing.

Varun Sundarkumar, Wanning Wang, Zoltan Nagy, Gintaras Reklaitis

Abstract read
In one paragraph

Article in International journal of pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Varun SundarkumarDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA. Electronic address: vsundark@purdue.edu.
Wanning WangDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Zoltan NagyDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Gintaras ReklaitisDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.

Funding

Risk-based process synthesis and Industry 4.0 framework for pharmaceutical manufacturing processesU01FD006738 · FDA · PURDUE UNIVERSITY · PI NAGY, ZOLTAN KALMAN · 2019 to 2021
$3.0M
FDA HHS U01 FD006738
6 · The paper itself

Abstract

The pharmaceutical industry has traditionally manufactured medicines in a limited range of dose strengths, with an emphasis on addressing the needs of the largest patient subgroups. This has disadvantaged smaller patient subsets, such as children, who often cannot find drug products in dosage levels suitable for their requirements. In recent years, development of pharmaceutical mini-tablets has emerged as an attractive solution to this problem. These are small-size dosages that offer attractive features such as flexible and personalized drug dosing, ease of swallowing, and tailored drug release, making them an excellent choice for administering medicines to children. This study presents a novel technique for manufacturing pharmaceutical mini-tablets, using a drop-on-demand (DoD) printing system. In this method, a DoD system is used to generate precise droplets of a melt-based formulation, which are then captured and solidified in an inert solvent bath to produce individual mini-tablets. The study also evaluates the performance of this technique for various formulations, and quantifies two critical quality attributes (CQAs) of the resulting mini-tablets: content uniformity and dissolution behavior. The findings demonstrate that the manufactured mini-tablets can meet regulatory specifications for both CQAs, and that their release profiles can be customized by modifying the excipients used. The study also discusses promising areas of application and limitations of this technique.

Indexed as

DeglutitionDrug IndustryChildExcipientsHumansPrinting, Three-DimensionalTabletsExcipientsTablets3D printingDrop-on-demand printingLow-dose high precision dosagesPediatric medicinePharmaceutical mini-tablets

Identifiers

PMID37647980
PMCPMC10808949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.